🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 22 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/02/2024 | 215,27 | 215,27 | 212,03 | 213,41 | -1,19% | 1,51% | 317.500 |
| 01/02/2024 | 214,97 | 217,72 | 213,50 | 215,97 | +0,55% | 1,96% | 296.900 |
| 31/01/2024 | 216,01 | 218,92 | 213,08 | 214,78 | -0,11% | 2,70% | 355.800 |
| 30/01/2024 | 216,09 | 216,87 | 214,21 | 215,02 | -0,87% | 1,23% | 227.000 |
| 29/01/2024 | 217,99 | 218,67 | 215,52 | 216,91 | -0,50% | 1,45% | 310.600 |
| 26/01/2024 | 220,06 | 221,81 | 217,09 | 218,01 | -0,60% | 2,14% | 223.400 |
| 25/01/2024 | 220,00 | 222,38 | 217,02 | 219,32 | +0,23% | 2,44% | 311.100 |
| 24/01/2024 | 217,78 | 219,82 | 216,22 | 218,81 | +0,47% | 1,65% | 295.600 |
| 23/01/2024 | 216,73 | 218,77 | 216,53 | 217,79 | +0,72% | 1,03% | 305.800 |
| 22/01/2024 | 217,60 | 218,68 | 215,47 | 216,24 | -0,73% | 1,48% | 320.000 |
| 19/01/2024 | 218,58 | 218,92 | 216,06 | 217,84 | -0,58% | 1,31% | 376.500 |
| 18/01/2024 | 222,68 | 222,75 | 217,13 | 219,11 | -1,41% | 2,52% | 358.200 |
| 17/01/2024 | 217,84 | 222,30 | 217,15 | 222,25 | +1,61% | 2,36% | 325.500 |
| 16/01/2024 | 218,48 | 220,90 | 216,06 | 218,72 | -0,15% | 2,22% | 358.300 |
| 12/01/2024 | 221,42 | 225,11 | 218,68 | 219,05 | -0,57% | 2,90% | 223.200 |
| 11/01/2024 | 220,00 | 222,52 | 215,89 | 220,30 | -0,61% | 3,01% | 469.300 |
| 10/01/2024 | 224,63 | 224,88 | 220,25 | 221,66 | -1,20% | 2,06% | 380.700 |
| 09/01/2024 | 229,59 | 230,50 | 221,98 | 224,36 | -2,89% | 3,71% | 334.200 |
| 08/01/2024 | 228,01 | 231,06 | 224,02 | 231,04 | +0,71% | 3,09% | 294.300 |
| 05/01/2024 | 229,17 | 230,85 | 226,48 | 229,40 | -0,31% | 1,91% | 265.100 |
| 04/01/2024 | 228,09 | 230,50 | 226,03 | 230,11 | +0,85% | 1,96% | 387.100 |
| 03/01/2024 | 227,85 | 228,79 | 226,27 | 228,18 | +0,37% | 1,11% | 353.800 |
| 02/01/2024 | 219,72 | 228,54 | 218,71 | 227,35 | +3,39% | 4,47% | 443.600 |
| 29/12/2023 | 219,02 | 220,70 | 217,57 | 219,89 | +0,30% | 1,43% | 258.200 |
| 28/12/2023 | 215,02 | 220,89 | 214,43 | 219,24 | +2,03% | 3,00% | 387.000 |
| 27/12/2023 | 215,30 | 218,07 | 214,11 | 214,88 | -0,64% | 1,84% | 388.800 |
| 26/12/2023 | 219,99 | 220,58 | 215,47 | 216,27 | -1,22% | 2,32% | 437.500 |
| 22/12/2023 | 219,45 | 223,91 | 218,79 | 218,93 | +0,30% | 2,33% | 423.700 |
| 21/12/2023 | 225,92 | 226,80 | 217,58 | 218,27 | -3,21% | 4,08% | 634.300 |
| 20/12/2023 | 240,27 | 240,70 | 225,15 | 225,51 | -6,14% | 6,47% | 1.095.400 |